Search research articles
Contact Us
Filters
Showing results (161-170 of 322) with videos related to
Page
of 33
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2026
Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [<sup>1</sup>⁸F]FDG PET/CT metrics in metastatic melanoma
Christos Sachpekidis, Theodoros P Vagenas, Marilena Müller, et al.
Cancers
|
March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Martin Salzmann, Alexander Wald, Henner Stege, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52
Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Cancers
|
June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival
Timo E Schank, Andrea Forschner, Michael Max Sachse, et al.
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
Current Biology : CB
|
September 20, 2005
STAT5 contributes to interferon resistance of melanoma cells
Claudia Wellbrock, Christin Weisser, Jessica C Hassel, et al.
Oncoimmunology
|
September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescence
Felix Funck, Jens Pahl, Lenka Kyjacova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
Christian Menzer, Bernd Beedgen, Joachim Rom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann, Hans P Sinn, Roland Penzel, et al.
ESMO Open
|
June 25, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, et al.
Page
of 33
Search research articles
Search
Showing results (161-170 of 322) with videos related to
Sort By:
Page
of 33
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2026
Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [<sup>1</sup>⁸F]FDG PET/CT metrics in metastatic melanoma
Christos Sachpekidis, Theodoros P Vagenas, Marilena Müller, et al.
Cancers
|
March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Martin Salzmann, Alexander Wald, Henner Stege, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52
Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Cancers
|
June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival
Timo E Schank, Andrea Forschner, Michael Max Sachse, et al.
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
Current Biology : CB
|
September 20, 2005
STAT5 contributes to interferon resistance of melanoma cells
Claudia Wellbrock, Christin Weisser, Jessica C Hassel, et al.
Oncoimmunology
|
September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescence
Felix Funck, Jens Pahl, Lenka Kyjacova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
Christian Menzer, Bernd Beedgen, Joachim Rom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann, Hans P Sinn, Roland Penzel, et al.
ESMO Open
|
June 25, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, et al.
Page
of 33